scispace - formally typeset
L

Luis M. Ruilope

Researcher at European University of Madrid

Publications -  891
Citations -  109166

Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.

Papers
More filters
Journal ArticleDOI

Impacto de las nuevas guías estadounidense y británica en el manejo y el tratamiento de las dislipemias en una población laboral española

TL;DR: La nuevas recomendaciones supondrian identificar a mas pacientes de alto riesgo y tratar con hipolipemiantes a mas poblacion que con las recomENDaciones europeas, lo that aumentaria los costes.
Journal ArticleDOI

Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.

TL;DR: In patients with Type 2 diabetes (T2D), risks of cardiovascular mortality and heart failure increase with decreasing kidney function (estimated glomerular filtration rate [eGFR]) and increasing albuminuria (urine albumin-to-creatinine ratio [UACR]). Finerenone, a selective, nonsteroidal mineralocorticoid receptor antagonist, improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and T2D in FIDELITY as discussed by the authors .
Journal ArticleDOI

Antihypertensive effectiveness of lercanidipine administered using an electronic pillbox compared with usual care in a cohort of mild-to-moderately hypertensive patients: the ELECTRA study

TL;DR: Whether the use of an electronic pillbox device (medical event monitoring system [MEMS]) could improve antihypertensive effectiveness of lercanidipine in a large group of hypertensive patients treated for 12 weeks is assessed.
Journal ArticleDOI

Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements

TL;DR: There are good reasons to use HBPM systematically in patients with CKD during long-term follow-up, and even if office BP is considered normal, it is still highly desirable to obtain out-of-office data.